Plasma neuropeptide Y concentrations in patients on hemodialysis.

Shigeru Akagi, Yoshio Nagake, Taro Sugimoto, Kazushi Nakao, Hiroko Yamasaki, Haruo Ichikawa, Hirofumi Makino

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

BACKGROUND: Neuropeptide Y (NPY) is a 36-amino-acid peptide that was originally isolated from the porcine brain. NPY, in contrast to leptin, is one of the most potent appetite stimulants. In some previous studies, NPY was found to be correlated with mean blood pressure (MBP) and fluid volume in patients on hemodialysis (HD), contributing to volume-induced hypertension. However, it is still unclear which NPY-sensitive neuronal pathways are responsible for the various changes seen in response to central NPY administration. In this study we analyzed the correlation of circulating levels of NPY with parameters of nutritional conditions, and we investigated the relationships between NPY concentrations and clinical markers of fluid volume in patients on HD. We also evaluated the effects of high-flux dialysis membranes on plasma NPY levels as compared with those of low-flux membrane. METHODS: Plasma NPY concentrations in patients on regular HD were measured using commercially available radioimmunoassay (RIA) kits. We examined the relationship between plasma NPY concentration and other clinical indices in patients on HD. RESULTS: Plasma NPY concentrations were inversely correlated with the serum urea nitrogen levels (r = -0.32) as well as protein catabolic rate (PCR) (r = -0.28). Plasma NPY was also correlated with the increase in body weight between HD sessions (r = 0.29). On the other hand, plasma NPY concentrations were not correlated with MBP, atrial natriuretic peptide (ANP), or adrenomedullin (AM). The reduction rate of plasma NPY with a high-flux dialysis membrane was significantly higher than that with a low-flux dialysis membrane. CONCLUSIONS: The secretion of NPY may be enhanced in a poor state of nourishment and stress induced by fluid volume overload in patients on HD, and plasma NPY is removed by a high-flux dialyzer.

Original languageEnglish
Pages (from-to)333-338
Number of pages6
JournalNephron
Volume92
Issue number2
DOIs
Publication statusPublished - Jan 1 2002

Fingerprint

Neuropeptide Y
Renal Dialysis
Dialysis
Membranes
Appetite Stimulants
Blood Pressure
Adrenomedullin
Atrial Natriuretic Factor
Leptin

ASJC Scopus subject areas

  • Physiology
  • Nephrology
  • Urology
  • Physiology (medical)

Cite this

Akagi, S., Nagake, Y., Sugimoto, T., Nakao, K., Yamasaki, H., Ichikawa, H., & Makino, H. (2002). Plasma neuropeptide Y concentrations in patients on hemodialysis. Nephron, 92(2), 333-338. https://doi.org/10.1159/000063296

Plasma neuropeptide Y concentrations in patients on hemodialysis. / Akagi, Shigeru; Nagake, Yoshio; Sugimoto, Taro; Nakao, Kazushi; Yamasaki, Hiroko; Ichikawa, Haruo; Makino, Hirofumi.

In: Nephron, Vol. 92, No. 2, 01.01.2002, p. 333-338.

Research output: Contribution to journalArticle

Akagi, S, Nagake, Y, Sugimoto, T, Nakao, K, Yamasaki, H, Ichikawa, H & Makino, H 2002, 'Plasma neuropeptide Y concentrations in patients on hemodialysis.', Nephron, vol. 92, no. 2, pp. 333-338. https://doi.org/10.1159/000063296
Akagi S, Nagake Y, Sugimoto T, Nakao K, Yamasaki H, Ichikawa H et al. Plasma neuropeptide Y concentrations in patients on hemodialysis. Nephron. 2002 Jan 1;92(2):333-338. https://doi.org/10.1159/000063296
Akagi, Shigeru ; Nagake, Yoshio ; Sugimoto, Taro ; Nakao, Kazushi ; Yamasaki, Hiroko ; Ichikawa, Haruo ; Makino, Hirofumi. / Plasma neuropeptide Y concentrations in patients on hemodialysis. In: Nephron. 2002 ; Vol. 92, No. 2. pp. 333-338.
@article{68549945151240f383827dd7ea286153,
title = "Plasma neuropeptide Y concentrations in patients on hemodialysis.",
abstract = "BACKGROUND: Neuropeptide Y (NPY) is a 36-amino-acid peptide that was originally isolated from the porcine brain. NPY, in contrast to leptin, is one of the most potent appetite stimulants. In some previous studies, NPY was found to be correlated with mean blood pressure (MBP) and fluid volume in patients on hemodialysis (HD), contributing to volume-induced hypertension. However, it is still unclear which NPY-sensitive neuronal pathways are responsible for the various changes seen in response to central NPY administration. In this study we analyzed the correlation of circulating levels of NPY with parameters of nutritional conditions, and we investigated the relationships between NPY concentrations and clinical markers of fluid volume in patients on HD. We also evaluated the effects of high-flux dialysis membranes on plasma NPY levels as compared with those of low-flux membrane. METHODS: Plasma NPY concentrations in patients on regular HD were measured using commercially available radioimmunoassay (RIA) kits. We examined the relationship between plasma NPY concentration and other clinical indices in patients on HD. RESULTS: Plasma NPY concentrations were inversely correlated with the serum urea nitrogen levels (r = -0.32) as well as protein catabolic rate (PCR) (r = -0.28). Plasma NPY was also correlated with the increase in body weight between HD sessions (r = 0.29). On the other hand, plasma NPY concentrations were not correlated with MBP, atrial natriuretic peptide (ANP), or adrenomedullin (AM). The reduction rate of plasma NPY with a high-flux dialysis membrane was significantly higher than that with a low-flux dialysis membrane. CONCLUSIONS: The secretion of NPY may be enhanced in a poor state of nourishment and stress induced by fluid volume overload in patients on HD, and plasma NPY is removed by a high-flux dialyzer.",
author = "Shigeru Akagi and Yoshio Nagake and Taro Sugimoto and Kazushi Nakao and Hiroko Yamasaki and Haruo Ichikawa and Hirofumi Makino",
year = "2002",
month = "1",
day = "1",
doi = "10.1159/000063296",
language = "English",
volume = "92",
pages = "333--338",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Plasma neuropeptide Y concentrations in patients on hemodialysis.

AU - Akagi, Shigeru

AU - Nagake, Yoshio

AU - Sugimoto, Taro

AU - Nakao, Kazushi

AU - Yamasaki, Hiroko

AU - Ichikawa, Haruo

AU - Makino, Hirofumi

PY - 2002/1/1

Y1 - 2002/1/1

N2 - BACKGROUND: Neuropeptide Y (NPY) is a 36-amino-acid peptide that was originally isolated from the porcine brain. NPY, in contrast to leptin, is one of the most potent appetite stimulants. In some previous studies, NPY was found to be correlated with mean blood pressure (MBP) and fluid volume in patients on hemodialysis (HD), contributing to volume-induced hypertension. However, it is still unclear which NPY-sensitive neuronal pathways are responsible for the various changes seen in response to central NPY administration. In this study we analyzed the correlation of circulating levels of NPY with parameters of nutritional conditions, and we investigated the relationships between NPY concentrations and clinical markers of fluid volume in patients on HD. We also evaluated the effects of high-flux dialysis membranes on plasma NPY levels as compared with those of low-flux membrane. METHODS: Plasma NPY concentrations in patients on regular HD were measured using commercially available radioimmunoassay (RIA) kits. We examined the relationship between plasma NPY concentration and other clinical indices in patients on HD. RESULTS: Plasma NPY concentrations were inversely correlated with the serum urea nitrogen levels (r = -0.32) as well as protein catabolic rate (PCR) (r = -0.28). Plasma NPY was also correlated with the increase in body weight between HD sessions (r = 0.29). On the other hand, plasma NPY concentrations were not correlated with MBP, atrial natriuretic peptide (ANP), or adrenomedullin (AM). The reduction rate of plasma NPY with a high-flux dialysis membrane was significantly higher than that with a low-flux dialysis membrane. CONCLUSIONS: The secretion of NPY may be enhanced in a poor state of nourishment and stress induced by fluid volume overload in patients on HD, and plasma NPY is removed by a high-flux dialyzer.

AB - BACKGROUND: Neuropeptide Y (NPY) is a 36-amino-acid peptide that was originally isolated from the porcine brain. NPY, in contrast to leptin, is one of the most potent appetite stimulants. In some previous studies, NPY was found to be correlated with mean blood pressure (MBP) and fluid volume in patients on hemodialysis (HD), contributing to volume-induced hypertension. However, it is still unclear which NPY-sensitive neuronal pathways are responsible for the various changes seen in response to central NPY administration. In this study we analyzed the correlation of circulating levels of NPY with parameters of nutritional conditions, and we investigated the relationships between NPY concentrations and clinical markers of fluid volume in patients on HD. We also evaluated the effects of high-flux dialysis membranes on plasma NPY levels as compared with those of low-flux membrane. METHODS: Plasma NPY concentrations in patients on regular HD were measured using commercially available radioimmunoassay (RIA) kits. We examined the relationship between plasma NPY concentration and other clinical indices in patients on HD. RESULTS: Plasma NPY concentrations were inversely correlated with the serum urea nitrogen levels (r = -0.32) as well as protein catabolic rate (PCR) (r = -0.28). Plasma NPY was also correlated with the increase in body weight between HD sessions (r = 0.29). On the other hand, plasma NPY concentrations were not correlated with MBP, atrial natriuretic peptide (ANP), or adrenomedullin (AM). The reduction rate of plasma NPY with a high-flux dialysis membrane was significantly higher than that with a low-flux dialysis membrane. CONCLUSIONS: The secretion of NPY may be enhanced in a poor state of nourishment and stress induced by fluid volume overload in patients on HD, and plasma NPY is removed by a high-flux dialyzer.

UR - http://www.scopus.com/inward/record.url?scp=0036781471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036781471&partnerID=8YFLogxK

U2 - 10.1159/000063296

DO - 10.1159/000063296

M3 - Article

C2 - 12218311

AN - SCOPUS:0036781471

VL - 92

SP - 333

EP - 338

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

IS - 2

ER -